Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity

By Todryk Stephen   Eaton Jonathan   Birchall Lindsay   Greenhalgh Rebecca   Soars Diane   Dalgleish Angus   Melcher Alan   Pandha Hardev  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 4, 2004-04 ,pp. : 323-330

Springer Publishing Company

Access to resources Recommend Favorite

Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy

By Merrick Alison   Diaz Rosa   O’Donnell Dearbhaile   Selby Peter   Vile Richard   Melcher Alan  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 6, 2008-06 ,pp. : 897-906

Springer Publishing Company

Access to resources Recommend Favorite

A new local ablation for solid malignant tumours: Anti-tumour effect of hyperthermal and electrochemical therapy on transplantable mouse cancer*

By Xie Lei   Sun Caijun  

International Journal of Hyperthermia, Vol. 22, Iss. 7, 2006-11 ,pp. : 607-612

Informa Healthcare

Access to resources Recommend Favorite

Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice

By Sirova Milada   Strohalm Jiri   Subr Vladimir   Plocova Daniela   Rossmann Pavel   Mrkvan Tomas   Ulbrich Karel   Rihova Blanka  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 1, 2007-01 ,pp. : 35-47

Springer Publishing Company

Access to resources Recommend Favorite

Glycosidated Phospholipids – a Promising Group of Anti-Tumour Lipids

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 4, 2014-05 ,pp. : 607-617

Bentham Science Publishers

Access to resources Recommend Favorite